View in EDS PDF Full Text

Patient-derived tumoroids and proteomic signatures: tools for early drug discovery.

Saved in:
Bibliographic Details
Title: Patient-derived tumoroids and proteomic signatures: tools for early drug discovery.
Authors: Lê H; Transgene S.A., Illkirch-Graffenstaden, France.; INSERM UMR1260, Regenerative Nanomedicine, Strasbourg, France., Deforges J; Transgene S.A., Illkirch-Graffenstaden, France., Cutolo P; Olink, Uppsala, Sweden., Lamarque A; Olink, Uppsala, Sweden., Hua G; INSERM UMR1260, Regenerative Nanomedicine, Strasbourg, France., Lindner V; INSERM UMR1260, Regenerative Nanomedicine, Strasbourg, France.; Department of Pathology, Hopitaux Universitaires de Strasbourg, Strasbourg, France., Jain S; Transgene S.A., Illkirch-Graffenstaden, France., Balloul JM; Transgene S.A., Illkirch-Graffenstaden, France., Benkirane-Jessel N; INSERM UMR1260, Regenerative Nanomedicine, Strasbourg, France., Quéméneur E; Transgene S.A., Illkirch-Graffenstaden, France.
Source: Frontiers in immunology [Front Immunol] 2024 Apr 18; Vol. 15, pp. 1379613. Date of Electronic Publication: 2024 Apr 18 (Print Publication: 2024).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38698850
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Patient-derived tumoroids and proteomic signatures: tools for early drug discovery.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lê+H%22">Lê H</searchLink>; Transgene S.A., Illkirch-Graffenstaden, France.; INSERM UMR1260, Regenerative Nanomedicine, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Deforges+J%22">Deforges J</searchLink>; Transgene S.A., Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Cutolo+P%22">Cutolo P</searchLink>; Olink, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Lamarque+A%22">Lamarque A</searchLink>; Olink, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Hua+G%22">Hua G</searchLink>; INSERM UMR1260, Regenerative Nanomedicine, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Lindner+V%22">Lindner V</searchLink>; INSERM UMR1260, Regenerative Nanomedicine, Strasbourg, France.; Department of Pathology, Hopitaux Universitaires de Strasbourg, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Jain+S%22">Jain S</searchLink>; Transgene S.A., Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Balloul+JM%22">Balloul JM</searchLink>; Transgene S.A., Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Benkirane-Jessel+N%22">Benkirane-Jessel N</searchLink>; INSERM UMR1260, Regenerative Nanomedicine, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Quéméneur+E%22">Quéméneur E</searchLink>; Transgene S.A., Illkirch-Graffenstaden, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Apr 18; Vol. 15, pp. 1379613. <i>Date of Electronic Publication: </i>2024 Apr 18 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38698850
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2024.1379613
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1379613
    Titles:
      – TitleFull: Patient-derived tumoroids and proteomic signatures: tools for early drug discovery.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lê H
      – PersonEntity:
          Name:
            NameFull: Deforges J
      – PersonEntity:
          Name:
            NameFull: Cutolo P
      – PersonEntity:
          Name:
            NameFull: Lamarque A
      – PersonEntity:
          Name:
            NameFull: Hua G
      – PersonEntity:
          Name:
            NameFull: Lindner V
      – PersonEntity:
          Name:
            NameFull: Jain S
      – PersonEntity:
          Name:
            NameFull: Balloul JM
      – PersonEntity:
          Name:
            NameFull: Benkirane-Jessel N
      – PersonEntity:
          Name:
            NameFull: Quéméneur E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 04
              Text: 2024 Apr 18
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1